Back
 JCDSA  Vol.4 No.1 , February 2014
Prevention and Treatment of Radiation Induced Skin Damage in Breast Cancer
Abstract: Introduction: Skin toxicity is a frequent side effect of radio and chemo-treatments in patients treated for breast cancer after conservative surgery. The aim of this paper is to report our experience in the management of skin toxicity evaluating radiotherapy planning and using preventive local aids. Materials and Methods: We have observed 300 patients undergoing radiotherapy. All received the prescription of a prophylactic moisturizing cream. Skin toxicity was valuated according to Acute Radiation Morbidity Scoring Criteria of the RTOG. Moreover, in a subgroup of 100 patients, we correlated the study of breast volume and features of treatment plans, with the addition of topic prophylactic treatment, using an oral therapy based on Resveratrol, Lycopene, Vitamin C and Anthocyanins (Ixor?). In another subgroup, 100 patients were subjected to corneometry assessing numerically skin hydration before, during and after radiotherapy. Results: In all patients, we related skin toxicity and the type of cream used. All patients completed the radiotherapy treatment, and G4 cutaneous toxicity was not observed in any of them. In patients treated with topic treatment and therapy based on Resveratrol, Lycopene, Vitamin C and Anthocyanins (Ixor?), the protective effect of (Ixor?) is more detected in patients with PTV (Planning Target Volume) <500 ml, when Dmax reaches values lower or equal to 107%, but not exceeding 110% of the prescribed dose, and in patients undergoing adjuvant chemotherapy with anthracyclines and taxanes. The values of corneometry allow us to evaluate the moisturizing effect for products used, and identify cases of skin toxicity in a first phase. Conclusions: Our study confirms the value of moisturizers in the prevention and resolution of radiotherapy-induced skin damage. An instrumental assessment of skin hydration with corneometry can help the radiation oncologist to use strategies that prevent the onset of toxicity of high degree.
Cite this paper: R. Franco, V. Ravo, S. Falivene, A. Argenone, V. Borzillo, F. Giugliano, E. Sammarco, M. Muto, S. Cappabianca and P. Muto, "Prevention and Treatment of Radiation Induced Skin Damage in Breast Cancer," Journal of Cosmetics, Dermatological Sciences and Applications, Vol. 4 No. 1, 2014, pp. 16-23. doi: 10.4236/jcdsa.2014.41003.
References

[1]   S. H. Moon, K. H. Shin, T. H. Kim, M. Yoon, S. Park, D. H. Lee, J. W. Kim, D. W. Kim, S. Y. Ark and K. H. Cho, “Dosimetric Comparison of Four Different External Beam Partial Breast Irradiation Techniques: Three-Dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy, Helical Tomotherapy, and Proton Beam Therapy,” Radiotherapy & Oncology, Vol. 90, No. 1, 2009, pp. 66-73.
http://dx.doi.org/10.1016/j.radonc.2008.09.027

[2]   J. P. Pignol, I. Olivotto, E. Rakovitch, S. Gardner, K. Sixel, W. Beckham, T. T. Vu, P. Truong, I. Ackermaan and L. Paszat, “A Multicenter Randomized Trial of Breast Intensity-Modulated Radiation Therapy to Reduce Acute Radiation Dermatitis,” Journal of Clinical Oncology, Vol. 26, No. 13, 2008, pp. 2085-2092. http://dx.doi.org/10.1200/JCO.2007.15.2488

[3]   A. G. Morganti, S. Cilla, V. Valentini, C. Digesù, G. Macchia, F. Deodato, G. Ferrandina, M. G. Cece, M. Cirocco, G. Garganese, L. Di Lullo, D. Traficante, F. Scarabeo, S. Panunzi, A. De Gaetano, G. Sallustio, N. Cellini, A. Piermattei and G. Scambia, “Phase I-II Studies on Accelerated IMRT in Breast Carcinoma: Tecnical Comparison and Acute Toxicity in 332 Patients,” Radiotherapy & Oncology, Vol. 90, No. 1, 2009, pp. 86-92. http://dx.doi.org/10.1016/j.radonc.2008.10.017

[4]   S. Tucker, I. Turesson and H. Thames, “Evidence of Individual Differences in the Radiosensitivity of Human Skin,” European Journal of Cancer, Vol. 28A, 1992, pp. 1782-1791.

[5]   D. Porock, L. Krisjanson, S. Nikoletti, F. Cameron and P. Pedler, “Predicting the Severity of Radiation Skin Reactions in Women with Breast Cancer,” Oncology Nursing Forum, Vol. 25, 1998, pp. 1019-1029.

[6]   B. Dubray, S. Delanian and J. L. Lefaix, “Effects of Mammary Radiotherapy on Skin and Subcutaneous Tissues,” Cancer/Radiothérapie, Vol. 1, No. 6, 1997, pp. 744-752. http://dx.doi.org/10.1016/S1278-3218(97)82951-4

[7]   D. Serin, L. Aimard, S. Kirscher, Y. Brewer, C. FelixFaure, P. Vincent, B. Chauvet and F. Reboul, “Adjuvant Combined Radiochemotherapy: A Feasibility Study of a New Strategy in Stages I and II,” Bulletin du Cancer, Vol. 84, 1997, pp. 247-253.

[8]   J. F. Weiss and M. R. Landauer, “Protection against Ionizing Radiation by Antioxidant Nutrients and Phytochemicals,” Toxicology, Vol. 189, No. 1-2, 2003, pp. 1-20. http://dx.doi.org/10.1016/S0300-483X(03)00149-5

[9]   Y. Z. Fang, S. Yang and G. Wu, “Free Radicals, Antioxidants, and Nutrition,” Nutrition, Vol. 18, No. 10, 2002, pp. 872-879. http://dx.doi.org/10.1016/S0899-9007(02)00916-4

[10]   Y. C. Oh, O. H. Kang, J. G. Choi, H. S. Chae, Y. S. Lee, O. O. Brice, H. J. Jung, S. H. Hong, Y. M. Lee and D. Y. Kwon, “Anti-Inflammatory Effect of Resveratrol by Inhibition of IL-8 Production in LPS-Induced THP-1 Cells,” The American Journal of Chinese Medicine, Vol. 37, No. 6, 2009, pp. 1203-1214. http://dx.doi.org/10.1142/S0192415X09007600

[11]   D. A. Benitez, M. A. Hermoso, E. Pozo-Guisado, P. M. Fernandez-Salguero and E. A. Castellon, “Regulation of Cell Survival by Resveratrol Involves Inhibition of NF Kappa B-Regulated Gene Expression in Prostate Cancer Cells,” Prostate, Vol. 69, No. 10, 2009, pp. 1045-1054.
http://dx.doi.org/10.1002/pros.20953

[12]   L. Bignotto, J. Rocha, B. Sepodes, M. Eduardo-Figueria, R. Pinto, M. Chaud, J. de Carvalho, H. Moreno Jr. and H. Mota-Filipe, “Anti-Inflammatory Effect of Lycopene on Carrageenan-Induced Paw Oedema and Hepatic Ischaemiareperfusion in the Rat,” British Journal of Nutrition, Vol. 102, No. 1, 2009, pp. 126-133. http://dx.doi.org/10.1017/S0007114508137886

[13]   C. Felgines, S. Talavera, O. Texier, C. Besson, V. Fogliano, J. L. Lamaison, L. Fauci, G. Galvano, C. Remesy and F. Galvano, “Absorption and Metabolism of Red Orange Juice Anthocyanins in Rats,” British Journal of Nutrition, Vol. 95, No. 5, 2006, pp. 898-904. http://dx.doi.org/10.1079/BJN 20061728

[14]   Gruppo di Lavoro AIRO per la Patologia Mammaria, “La Radioterapia dei Tumori della Mammella—Indicazioni e Criteri Guida,” AIRO, Graft Prints, 2009.

[15]   International Commission of Radiation Units and Measurements, “ICRU Report 50: Prescribing, Recording, and Reporting Photon Beam Therapy,” International Commission of Radiation Units and Measurements, Bethesda, 1993.

[16]   J. D. Cox, J. Stetz and T. F. Pajak, “Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC),” International Journal of Radiation Oncology * Biology * Physics, Vol. 31, No. 5, 1995, pp. 1341-1346.
http://dx.doi.org/10.1016/0360-3016(95)00060-C

[17]   P. Poortmans, “A Bright Future for Radiotherapy in Breast Cancer,” Radiotherapy & Oncology, Vol. 82, No. 3, 2007, pp. 243-246. http://dx.doi.org/10.1016/j.radonc.2007.02.003

[18]   D. A. Benitez, M. A. Hermoso, E. Pozo-Guisado, P. M. Fernandez-Salguero and E. A. Castellon, “Regulation of Cell Survival by Resveratrol Involves Inhibition of NF Kappa B-Regulated Gene Expression in Prostate Cancer Cells,” Prostate, Vol. 69, No. 10, 2009, pp. 1045-1054.
http://dx.doi.org/10.1002/pros.20953

[19]   S. Reagan-Shaw, H. Mukhtar and N. Ahmad, “Resveratrol Imparts Photoprotection of Normal Cells and Enhances the Efficacy of Radiation Therapy in Cancer Cells,” Photochemistry and Photobiology, Vol. 84, No. 2, 2008, pp. 415-421. http://dx.doi.org/10.1111/j.1751-1097.2007.00279.x

[20]   T. B. Fitzpatrick, A. Z. Eisen, K. Wolff, I. M. Freedberg and K. F. Austen, “Dermatology in General Medicine,” McGraw-Hill, 1993, pp. 1692-1695.

[21]   U. Heinrich, U. Koop, M. C. Leneveu-Duchemin, K. Osterrieder, S. Bielfeldt, C. Chkarnat, J. Degwert, D. Hantschel, S. Jaspers, H. P. Nissen, M. Rohr, G. Schneider and H. Tronnier, “Multicentre Comparison of Skin Hydration in Terms of Physical-, Physiologicaland Product-Dependent Parameters by the Capacitive Method (Corneometer CM 825),” International Journal of Cosmetic Science, Vol. 25, No. 1-2, 2003, pp. 45-51. http://dx.doi.org/10.1046/j.1467-2494.2003.00172.x

[22]   J. F. Weiss and M. R. Landauer, “Protection against Ionizing Radiation by Antioxidant Nutrients and Phytochemicals,” Toxicology, Vol. 189, No. 1-2, 2003, pp. 1-20. http://dx.doi.org/10.1016/S0300-483X(03)00149-5

[23]   V. Ravo, M. G. Calvanese, R. Di Franco, V. Crisci, P. Murino, R. Manzo, A. Morra, F. Cammarota and P. Muto, “Prevention of Cutaneous Damages Induced by Radiotherapy in Breast Cancer: An Institutional Experience,” Tumori, Vol. 97, 2011, pp. 750-754.

[24]   R. Di Franco, M. G. Calvanese, P. Murino, R. Manzo, C. Guida, D. Di Gennaro, C. Anania and V. Ravo, “Skin Toxicity from External Beam Radiation Therapy in Breast Cancer Patients: Protective Effects of Resveratrol, Lycopene, Vitamin C and Amthocianin (Ixor?),” Radiation Oncology, Vol. 7, 2012, p. 12. http://dx.doi.org/10.1186/1748-717X-7-12

[25]   R. Di Franco, E. Sammarco, M. G. Calvanese, F. De Natale, S. Falivene, A. Di Lecce, F. M. Giugliano, P. Murino, R. Manzo, S. Cappabianca, P. Muto and V. Ravo, “Preventing the Acute Skin Side Effects in Patients Treated with Radiotherapy for Breast Cancer: The Use of Corneometry in Order to Evaluate the Protective Effect of Moisturizing Creams,” Radiation Oncology, Vol. 8, 2013, p. 57.
http://dx.doi.org/10.1186/1748-717X-8-57

[26]   O. Gozzo Tde, M. S. Panobianco, M. J. Clapis and A. de Almeida, “Dermatological Toxicity in Women with Breast Cancer Undergoing Chemotherapy Treatment,” Revista Latino-Americana de Enfermagem, Vol. 18, No. 4, 2010, pp. 681-687.

[27]   Y. Z. Fang, S. Yang and G. Wu, “Free Radicals, Antioxidants, and Nutrition,” Nutrition, Vol. 18, No. 10, 2002, pp. 872-879. http://dx.doi.org/10.1016/S0899-9007(02)00916-4

[28]   J. Pinnagoda, R. Tupker, P. J. Coenraads and J. P. Nater, “Mesaurement of Transepidermal Water Loss,” In: J. Serup and G. B. E. Jemec, Eds., Nonivasive Methods and the Skin, CRC Press, Boca Raton, 1995, pp. 173-178.

[29]   M.-F. Chen, W.-C. Chen, C.-H. Lai, C.-H. Hung, K.-C. Liu and Y.-H. Cheng, “Predictive Factors of Radiation-Induced Skin Toxicity in Breast Cancer Patients,” BMC Cancer, Vol. 10, 2010, p. 508. http://dx.doi.org/10.1186/1471-2407-10-508

[30]   M. Schmuth, M. A. Wimmer, S. Hofer, A. Sztankay, G. Weinlich, D. M. Linder, P. M. Elias, P. O. Fritsch and E. Fritsch, “Topical Corticosteroid Therapy for Acute Radiation Dermatitis: A Prospective, Randomized, Double-Blind Study,” British Journal of Dermatology, Vol. 146, No. 6, 2002, pp. 983-991. http://dx.doi.org/10.1046/j.1365-2133.2002.04751.x

[31]   C. W. Blichmann and J. Serup, “Assessment of Skin Moisture. Measurement of Electrical Conductance, Capacitance and Transepidermal Water Loss,” Acta DermatoVenereologica, Vol. 68, 1998, pp. 284-290.

 
 
Top